Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The reporting person's ownership consists of (i) 0 shares of common stock, (ii) 500,000 warrants to purchase shares of common stock (the "B Warrants") and (iii) 57,143 shares of common stock issuable to the reporting person pursuant to convertible securities entered into between Lind Global Fund II and ABVC BioPharma, Inc. (the "Convertible Securities").


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The reporting person's ownership consists of (i) 0 shares of common stock, (ii) 500,000 B Warrants and (iii) 57,143 shares of common stock issuable to the reporting person pursuant to the Convertible Securities.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The reporting person's ownership consists of (i) 0 shares of common stock, (ii) 500,000 B Warrants and (iii) 57,143 shares of common stock issuable to the reporting person pursuant to the Convertible Securities.


SCHEDULE 13G



 
Lind Global Fund II LP
 
Signature:By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton
Name/Title:Jeff Easton, Managing Member
Date:08/13/2025
 
Lind Global Partners II LLC
 
Signature:/s/ Jeff Easton
Name/Title:Jeff Easton, Managing Member
Date:08/13/2025
 
EASTON JEFF
 
Signature:/s/ Jeff Easton
Name/Title:Jeff Easton
Date:08/13/2025